Moderna Announces New Supply Agreement for 2023 with Switzerland for Additional Seven Million Doses of Moderna's COVID-19 Booster Vaccine

Moderna Inc ,a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a new supply agreement with the Swiss Federal Government for seven million doses of Moderna's COVID-19 booster vaccine for anticipated delivery in 2023 and an additional option of seven million doses for delivery in 2023 and 2024.

These doses are in addition to the seven million doses of Moderna's booster vaccine that are scheduled for supply to Switzerland in the second half of 2022, which the Government exercised its option to purchase in December 2021.